tbuckley/cabot-search huggingface dataset:
Clonal Hematopoiesis in Patients with Chronic Lymphocytic Leukemia Treated with Fixed-Duration Venetoclax-Obinutuzumab or Chlorambucil-Obinutuzumab: Insights from the Randomized CLL14 Trial
Authors: Othman Al-Sawaf, Benjamin N. Locher, Friederike Christen, Sandra Robrecht, Can Zhang, Anna Maria Fink, Eugen Tausch, Christof Schneider, Matthias Ritgen, Karl Anton Kreuzer, Coral Fustero, Raphael Hablesreiter, John F. Seymour, Piers Blombery, Lars Bullinger, Brenda Chyla, Hyun Yong Jin, Yanwen Jiang, Stephan Stilgenbauer, Barbara F. Eichhorst, Michael J. Hallek, Kirsten Fischer, Frederik Damm
Journal: Blood (2024)
CD123-CAR T Cells Manufactured in the Presence of Dasatinib Induce High Grade CRS and/or IEC-HS without Improving Efficacy in Pediatric Patients with Recurrent/Refractory Leukemia
Authors: Swati Naik, Madden Renee, Aimee C. Talleur, Rebecca Epperly, Timothy Lockey, Jennyfer Bran, Liqing Tian, Ying Li, Dinesh Keerthi, Alexandra Boyd, Amanda Lipsitt, Jeffrey E. Rubnitz, Jeffery M Klco, Barry Shulkin, Sarah Schell, Polly Adams, Jeoungeun John Park, Janice Riberdy, Na Shang, Jaquelyn T. Zoine, Raghuvaran Shanmugam, Chris Nevitt, Unmesha Thanekar, Jennifer Wallace, Elaine Harstead, Scott Perry, Catherine Willis, Jean-Yves Metais, Deanna M. Langfitt, Sheng Zhou, Salem M. Akel, Caitlin Zebley, Jeremy Chase Crawford, Benjamin Youngblood, Paul G. Thomas, Frank Fazio, Brandon M Triplett, Stephen Gottschalk, Mireya Paulina Velasquez
Journal: Blood (2024)
Flow Cytometry-Based Assessment of the Proportion of Monoclonal Plasma Cells in Synthetic Phase (S-phase) Is an Independent Marker of Adverse Prognosis in Patients with Newly Diagnosed Multiple Myeloma
Authors: Saurabh Zanwar, Dragan Jevremovic, Prashant Kapoor, Horatiu Olteanu, Francis Buadi, Pedro Horna, Wilson I. Gonsalves, Gregory Otteson, Suzanne R Hayman, Nadine Abdallah, Moritz Binder, Joselle Cook, Angela Dispenzieri, David Dingli, Morie A. Gertz, Taxiarchis Kourelis, Nelson Leung, Yi Lin, Eli Muchtar, Rahma M Warsame, Amie Fonder, Miriam Hobbs, Yi Lisa Hwa, Michelle G. Rogers, Robert A. Kyle, Vincent Rajkumar, Shaji Kumar
Journal: Blood (2024)
Combination of Glofitamab with Pirtobrutinib in BTK Inhibitor (BTKi)-Naive or Btki-Intolerant Patients with Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): A Multicenter Phase 2 Study of the University of California Hematologic Malignancies Consortium
Authors: Madhav R Seshadri, Chiung-Yu Huang, Hildy Donner, William B. Pearse, Patricia A. Young, Monica Mead, Naseem S. Esteghamat, Christine Thacker, Lauren Nguyen, Weiyun Ai, Michael A Spinner, Lawrence David Kaplan, Charalambos Andreadis
Journal: Blood (2024)
Asymptomatic Multicentric Castleman Disease: A Potential Early Stage of Idiopathic Mcd
Authors: Lu Zhang, Qinhua Liu, Hui Zhou, Huilai Zhang, Yujun Dong, Xiaobo Wang, Luqun Wang, Liping Su, Xiaojing Yan, Yan Li, Mingzhi Zhang, Kaiyang Ding, Hui-Han Wang, Hongling Peng, Liye Zhong, Lin Yang, Lintao Bi, Da Gao, Guangxun Gao, Liang Huang, Chunyan Sun, Jia Song, Wenbin Qian, Wenrong Huang, Zhenling Li, Yao Liu, Jian Li
Journal: Blood (2024)
Combined Effects of Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy and Acute Graft-Versus-Host Disease on Requiring Renal Replacement Therapy in US Patient Population - a Secondary CIBMTR Analysis
Authors: Udit Nangia, Leland Metheny, Deepak Chandramohan, Hari Naga Garapati, Prathap Simhadri, Neeraj Mahajan
Journal: Blood (2024)
Loss of Microtubule Protein Stathmin-1 Impairs Autophagy in Hematopoietic Stem Cells
Authors: Luana Chiquetto Paracatu, Qian Dong, Mia G Warmka, Liana Valin, Patrick Hunt, Ashley Jones, Meg Schuetz, Mousumi Chakraborty, Zev Greenberg, Christine RC Zhang, Grant A Challen, Cliff Luke, Robert Signer, Wandy Beatty, David Kast, Stephen Sykes, Laura G. Schuettpelz
Journal: Blood (2024)
CML Patients Who Fail to Achieve ≤ 1% BCR::ABL1 at 12 Months or ≤ 0.1% BCR::ABL1 at 24 Months (major molecular response, MMR) Show Significantly Inferior Survival, but Not Due to CML-Related Deaths: Data from an Italian Real-Life Observational Study
Authors: Valentina Giai, Tiziana Rosso, Fausto Castagnetti, Patrizia Pregno, Massimiliano Bonifacio, Isabella Capodanno, Mario Tiribelli, Fabio Stagno, Giovanni Caocci, Antonella Gozzini, Luigiana Luciano, Sara Galimberti, Monica Bocchia, Andrea Patriarca, Giuseppe Lanzarone, Bruno Martino, Anna Guella, Anna Rita Scortechini, Carmen Fava, Claudio Fozza, Simona Sica, Nicola Di Renzo, Pellegrino Musto, Domenico Pastore, Alessandro Maggi, Michele Pizzuti, Lorella Maria Antonia Melillo, Angelo Michele Carella, Giuseppe Tarantini, Anna Mele, Elisabetta Calistri, Maria Rosaria Coppi, Fabio Saccona, Emilia Scalzulli, Beatrice Battaglio, Miriam Iezza, Cinzia Bitetti, Roberto Freilone, Gianantonio Rosti, Francesco Albano, Fabrizio Pane, Giorgina Specchia, Massimo Breccia, Giovannino Ciccone, Giuseppe Saglio
Journal: Blood (2024)
Mosunetuzumab and Zanubrutinib in Relapsed/Refractory Follicular Lymphoma Patients (MOZART): A Phase II, Chemo-Free Trial from Fondazione Italiana Linfomi (FIL)
Authors: Marco Ladetto, Rita Tavarozzi, Matthew Ku, Luca Arcaini, Carola Boccomini, Beatrice Casadei, Annalisa Chiarenza, Annarita Conconi, Ilaria Del Giudice, Michele Merli, Maria Elena Nizzoli, Stefano Luminari
Journal: Blood (2024)
Large-Scale Transcriptome Analysis Supports Genomic Taxonomy and Predicts Response to Hypomethylating Agents in Myelodysplastic Neoplasms
Authors: Gabriele Todisco, Matteo Zampini, Pedro Luis Moura, Alessandro Buizza, Teresa Mortera-Blanco, Anna Tranberg, Elena Riva, Maria Creignou, Alessia Campagna, Marta Ubezio, Ann-Charlotte Björklund, Bianca Tesi, Indira Barbosa, Denise Ventura, Francesca Ficara, Elli Papaemmanuil, Armando Santoro, Magnus Tobiasson, Elsa Bernard, Matteo Giovanni Della Porta, Eva Hellstrom Lindberg
Journal: Blood (2024)
Clonal Evolution during Dual B Cell Receptor Pathway Inhibitor Therapy with Acalabrutinib and Umbralisib in CLL Patients
Authors: Saurabh Yadav, Sumbul Jawed Khan, Binu Kandathilparambil Sasi, Elizabeth F. Cohen, Kiyomi Mashima, Hannah Cormier, Stacey M. Fernandes, Samantha J. Shupe, Roberta Santos Azevedo, Mariia Mikhaleva, Philippe Armand, David C. Fisher, Matthew S. Davids, Inhye E. Ahn, Michael Y. Tolstorukov, Mark A. Murakami, Jennifer R. Brown
Journal: Blood (2024)
Comparison of Riete and Some Scores for Predicting Cancer in Unprovoked Thrombosis
Authors: Abdulrahman Al Raizah, Mohammed Ziyadah, Abdulaziz Alahmary, Nahla Wahby, Albarra Madkhali, Abdullah S. Al Saleh, Mohsen Al Zahrani, Aymen Hejazi, Ahmed Alaskar
Journal: Blood (2024)
<i>Outcomes and Toxicity Profile in Elderly and Very-Elderly Diffuse Large B-Cell Lymphoma Patients: A Real-World and Comparative Study Involving Three Different Dose-Modulated Anthracycline-Based Immunochemotherapy Regimens in LATAM</i>
Authors: Luís Alberto de Pádua Covas Lage, Rita Novello de Vita, Cadiele Oliana Reichert, Hebert Fabrício Culler, Fábio Alessandro de Freitas, Lucas Bassolli De Oliveira Alves, Mayara D'Auria Jacomassi, Vanderson Rocha, Sheila Aparecida Coelho da Siqueira, Renata de Oliveira Costa, Juliana Pereira
Journal: Blood (2024)
Golseek-2: A Phase 2 Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Golcadomide in Combination with Rituximab in Participants with Newly Diagnosed Advanced Stage Follicular Lymphoma
Authors: Jose C. Villasboas Bisneto, Pier Luigi Zinzani, Andrew J. Davies, Robert Kridel, Guilherme Fleury Perini, Parth Rao, Joanna Mikita-Geoffroy, Akshay Sudhindra, Charalambos Andreadis
Journal: Blood (2024)
FAS Ablation Confers Resistance to Allogeneic CAR-T Rejection By T Cells in Absence of NK Cell Sensitization
Authors: Silvia Menegatti, Sheila Lopez-Cobo, Aurelien Sutra Del Galy, Jaime Fuentealba, Lisseth Silva, Laeticia Perrin, Sandrine Heurtebise-Chrétien, Valentine Pottez-Jouatte, Aurélie Darbois, Nina Burgdorf, Albane Simon, Marguerite Laprie-Santenac, Michael Saitakis, Bruce Wick, Beau R Webber, Branden S Moriarity, Olivier Lantz, Sebastian Amigorena, Laurie Menger
Journal: Blood (2024)
Multicenter Retrospective Cohort Study of 694 Patients with Ocular Adnexal Marginal Zone B-Cell Lymphoma on Behalf of the Chinese Ocular Lymphoma Collaborative Group (COLCG)
Authors: Xin Li, Jia Wei, Dong-feng Zeng, Shu-nan Qi, Bingzong Li, Wei Guo, Li Wang, Yajun Li, Xudong Zhang, Yong Yang, Shukai Qiao, Yan Zeng, Yunfei Song, Jing-wen Wang, Jian-min Ma, Liang Wang
Journal: Blood (2024)
Cost Consequence and Time Toxicity Model for the Treatment of Third-Line or Later (3L+) Follicular Lymphoma (FL) Using Advanced Therapies: A Comparison of Lisocabtagene Maraleucel (liso-cel) with Mosunetuzumab
Authors: Saurabh Dahiya, Ashley C. Saunders, Jinender Kumar, William Ngantung, Matia Saeedian
Journal: Blood (2024)
Environmental Pollution Is Associated with Higher Risk MDS in a Diverse Urban Cohort and Triggers Inflammation in a Murine Models
Authors: Megha Verma, Matthew P Davidsohn, Srabani Sahu, Kith Pradhan, Seyedeh Shareh Dehghani, Sakshi Jasra, Ritesh Aggarwal, Hui Zhang, Michael Wysota, Divij Verma, Amit Verma, Dean Hosgood, Yiyu Zou, Aditi Shastri
Journal: Blood (2024)
Trial in Progress: Open-Label Phase 1 Study to Evaluate Safety of SGN-35C in Adults with Select Relapsed/Refractory Lymphomas (SGN35C-001)
Authors: Alex F. Herrera, Swetha Kambhampati, Michael A Spinner, Christina Poh, Elizabeth H. Phillips, Vincent Ribrag, Ming Jin Yan, Tara Chen, Julie M. Vose
Journal: Blood (2024)
CD38-SADA Pretargeted Radioimmunotherapy (PRIT) with Lutetium 177 (Lu177)-DOTA in Adult Patients with Relapsed or Refractory Non-Hodgkin Lymphoma: A First-in-Human Phase 1 Trial
Authors: Jasmine Zain, Jeffrey Wong, Steven Horwitz, Neeta Pandit-Taskar, Anas Al-Janadi, Brandon Mancini, Rizwan Khawaja, Christina Y. Lee, Adrian Howansky, Darla Liles, Aidan Burke, Brian H. Santich, Danny Klindt Fonnes, Vignesh Rajah, Norman LaFrance, Charlotte A. Russell
Journal: Blood (2024)
Novel Machine Learning Approaches Tailored to Protein Configuration Predict Drug Vulnerabilities in Myeloid Neoplasia
Authors: Arda Durmaz, Carlos Bravo-Perez, Zachary Brady, Matteo D'Addona, Luca Guarnera, Serhan Unlu, Hussein Awada, Praveena Thiagarajan, Yuriy Fedorov, Drew Adams, Carmelo Gurnari, Jacob G. Scott, Jaroslaw Maciejewski, Valeria Visconte
Journal: Blood (2024)
Identification and Characterization of Distinct Pathways for Platelet Replenishment in Steady-State Hematopoiesis
Authors: Stefania Mazzi, Tetsuichi Yoshizato, Joana Carrelha, Kari Högstrand, Axel Winroth, Masafumi Seki, Bishan Wu, Ellen Markljung, Amy Hillen, Edwin Chari, Petter Woll, Sten Eirik Waelgaard Jacobsen
Journal: Blood (2024)
Convenience Versus Continuity: A Natural History Study of a Newly Opened Plasma Cell Disorders Clinic in an Underserved Community and Desire for Transfer of Care Among Previously Diagnosed Patients
Authors: Michael Slade, Ravi Vij, Keith Stockerl-Goldstein, Mark A. Schroeder, Angela Vickroy, Margaret Kavanaugh, Carmen Wilson, Mark Fiala
Journal: Blood (2024)
Angioimmunoblastic Versus Non-Angioimmunoblastic Nodal T-Follicular Helper Cell Lymphomas: Single Center Retrospective Analysis on 208 Cases
Authors: Benedetta Sordi, Ozgur Can Eren, Nivetha Ganesan, Varun Iyengar, Robert Stuver, William T. Johnson, Alison Moskowitz, Paola Ghione, Natasha Galasso, Ellie Casper, Tiffany Chang, Helen Hancock, Theresa Davey, Alexander P. Boardman, Philip Caron, Kevin A. David, Lorenzo Falchi, Paul A. Hamlin, Andrew M. Intlekofer, Anita Kumar, Efrat Luttwak, Ariela Noy, Colette Owens, Maria Lia Palomba, Gilles Salles, Raphael E. Steiner, Pallawi Torka, Santosha A. Vardhana, Ahmet Dogan, Steven Horwitz, Zachary D. Epstein-Peterson
Journal: Blood (2024)
Serum O-Glycan Antigenicity in Pediatric Immune Thrombocytopenia Predicts Disease Persistence
Authors: Katelyn E. Rosenbalm, George Steinhardt, Melissa M. Lee-Sundlov, Alejandro Roisman, Shikan Zheng, Amanda B. Grimes, Taylor Olmsted Kim, Karin M. Hoffmeister
Journal: Blood (2024)
Newborn Screening Program (NBS) for Early Detection of Sickle Cell Disease and G6PD: The Saudi Experience
Authors: Hatoon Ezzat, Meshal Alshehri, Ibrahim Alghamdi, Fayez Alshehri, Najwa Kariri, Fayzah Albalawi, Nourah Aldoaiji, Mohammed Al Abdulaali
Journal: Blood (2024)
Lower Mycophenolic Acid Exposure in Patients Undergoing Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide/ Cyclosporine a-Based GvHD Prophylaxis - Need for Dose Intensification
Authors: Aswin Anand Pai, John C Panetta, Nayanthara Bijukumar, Rachel Mariam Renji, Manoj A, Agila Jayaraman, Sujith Karumathil, Anu Korula, Sushil Selvarajan, Alok Srivastava, Aby Abraham, Vikram Mathews, Biju George, Uday Kulkarni, Poonkuzhali Balasubramanian
Journal: Blood (2024)
A Pilot Trial of Low Dose-Mosunetuzumab for Low-Tumor Burden Indolent B-Cell Lymphoma: Trial in Progress
Authors: Carrie I Ho, Mengyang Di, Ryan C Lynch, Christina Poh, Vikram Raghunathan, Mazyar Shadman, Stephen D. Smith, Brian G. Till, Paul S Martin, Chaitra S. Ujjani, Ajay K. Gopal
Journal: Blood (2024)
HOPE-PMF: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess Efficacy and Safety of Ropeginterferon Alfa-2b in Patients with Early/Lower-Risk Primary Myelofibrosis
Authors: Ghaith Abu-Zeinah, Albert Qin, Harinder Gill, Norio Komatsu, John O. Mascarenhas, Weichung Joe Shih, Oleh Zagrijtschuk, Toshiaki Sato, Kazuya Shimoda, Richard T. Silver, Ruben A. Mesa
Journal: Blood (2024)
Bomedemstat (MK3543) in Combination with Ruxolitinib in Patients with Advanced Myelofibrosis
Authors: Harinder Gill, Lester Au, Dorothy Tsai, Rita Yim, Vivian Li, Paul Lee, Lynn Chin, Qi Zhang, Garret Man Kit Leung, Tony Kwun Yat Wu, Hugh Young Rienhoff
Journal: Blood (2024)
Autologous B Cell Maturation Antigen (BCMA) and CD19 Dual Targeting Fastcar-T Cells (GC012F/AZD0120) As First-Line Therapy for Elderly Patients with Newly Diagnosed Multiple Myeloma Patients
Authors: Juan Du, Wanting Qiang, Jing Lu, Yanchun Jia, Haiyan He, Jin Liu, Pei Guo, Ying Yang, Zhongyuan Feng, Lina Jin, Xiaoqiang Fan, Nina Shah, Qi Zhang, Jia Liu, Lihong Weng, Lianjun Shen, Wei Cao
Journal: Blood (2024)
Alloreactive Vs IL15 <i>Ex Vivo</i> Stimulated Natural Killer Cells As Adoptive Cell Therapy in Haploidentical Transplantation for Pediatric Acute Leukemia: A Phase I/II Clinical Trial
Authors: Carmen Mestre Durán, Odelaisy Leon Triana, Lidia Pertiñez, David Bueno, Luisa Sisinni, Isabel Badell, Marta González Vicent, Cristina Belendez, Pilar Palomo Moraleda, Yasmina Mozo, Laura Clares Villa, Carlos Echecopar, Karima Al-Akioui Sanz, Victor Galan-Gomez, Pilar Guerra Garcia, Cristina Aguirre, Carlos Solano, Antonio Perez Martinez
Journal: Blood (2024)
<i>DNMT3A, TET2, and ASXL1</i> (DTA) Mutations Are Associated with Thrombosis and Bleeding in Patients with Myeloproliferative Neoplasms
Authors: Arnon Haran, Avital Wasserstrom, Shlomzion Aumann, Vladimir Vainstein, Romi Kazoom, Batia Roth Jelinek, Ariela Arad, Noa Buchman, Ela Shai, Yossi Kalish, Moshe E Gatt, Eran Zimran
Journal: Blood (2024)
MRD Detection in Standard-Risk Pediatric AML Using Single-Cell RNA Sequencing
Authors: Rula Gladden, Everett Fan, Shruti Bhise, Rhonda E. Ries, Rachel Ferina, Sami B. Kanaan, Mark A Mendoza, Jobelle Peralta, Rachel Gate, Soheil Meshinchi, Scott N Furlan
Journal: Blood (2024)
Immune-Scape in Myeloid Sarcoma and Acute Myeloid Leukemia
Authors: Juliana Alvarez Argote, Kristin E Zorn, Cary Stelloh, Alison E Meyer, Maria E Hintzke, Ashley Cunningham, Emily Giever, George S Vassiliou, Ehab L. Atallah, Sridhar Rao
Journal: Blood (2024)
Exploration of the Specific Mechanism of EGR2 Hotspot Mutation Mediating the Upregulation of Galectin-1 Expression in the Progression of CLL Following Treatment with BTK Inhibitor
Authors: Xiao Lu, Yeqin Sha, Xinyu Song, Luomengjia Dai, Ziyuan Zhou, Hanning Tang, Yi Miao, Shuchao Qin, Yi Xia, Tonglu Qiu, Lei Fan, Jianyong Li, Huayuan Zhu
Journal: Blood (2024)
Low Immunoglobulin G and Low Lymphocyte-Monocyte Ratio at the End of Treatment Predict Early Progression in Diffuse Large B-Cell Lymphoma
Authors: Hideki Uryu, Masaharu Kawashima, Kazuhito Suzuki, Ryoko Fukushima, Tadahiro Gunji, Hiroto Ishii, Kei Hirano, Riku Nagao, Hiroki Yokoyama, Atsushi Katsube, Susumu Tanoue, Yo Sakayori, Yasutaka Mochizuki, Keita Ishii, Rie Ohba, Kurumi Tsukamoto, Daiki Hattori, Mitsuji Katori, Takeshi Saito, Kaichi Nishiwaki, Nobuaki Dobashi, Shingo Yano
Journal: Blood (2024)
CTEP 10590, NORM: Nodular Lymphocyte Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase II Trial with Either Rituximab or Mosunetuzumab
Authors: Raphael Steiner, Allison M. Bock, Alex F. Herrera, Omer Zulfa, Marc Hoffmann, Sami Ibrahimi, Natalie Galanina, Hun Ju Lee, Michael Green, Ruitao Lin, Chelsea C. Pinnix, Alison Moskowitz, Joachim Yahalom, Dai Chihara
Journal: Blood (2024)
Incidence, Risk Factors, and Prognostic Implications of Heart Failure Hospitalizations Among Patients with Myeloproliferative Neoplasms
Authors: Orly Leiva, Steven Soo, Nathaniel Smilowitz, Harmony Reynolds, Binita Shah, Samuel Bernard, Michelle Hyunju Lee, Chi-Joan How, Gabriela S. Hobbs
Journal: Blood (2024)
A Multicenter, Open-Label, Phase 3, Randomized Controlled Trial of Duvelisib Versus Investigator's Choice of Gemcitabine or Bendamustine in Patients with Relapsed/Refractory Nodal T Cell Lymphoma with T Follicular Helper Phenotype
Authors: Kate Cwynarski, Eva Domingo Domenech, David Sidransky, Ohad S Bentur, Pier Luigi Zinzani
Journal: Blood (2024)
Innovative Bone Marrow CAR-T Cell Manufacturing for AML: Enhancing Viability and Tumor Migration
Authors: Jose Antonio Bejarano Garcia, Daniel Primo, Maria Jose Palacios Barea, Belén Sierro, Beatriz Guijarro-Albaladejo, Xian Weng, Miranda Omenaca, Estefania Garcia-Guerrero, Joan Ballesteros, Jose Antonio Pérez-Simón
Journal: Blood (2024)
Zanubrutinib Plus Ixazomib &amp; Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia:a Phase II Studyshort Title: Zid for Waldenström Macroglobulinemia
Authors: Xiong Wenjie, Yuting Yan, Tingyu Wang, Weiwei Sui, Ying Yu, Tengteng Yu, Rui Lyu, Wei Liu, Huimin Liu, Gang An, Wenyang Huang, Dehui Zou, Lu-Gui Qiu, Shuhua Yi
Journal: Blood (2024)
Rewiring Cancer Drivers to Induce Apoptosis By Transcriptional Chemical Inducers of Proximity in Chronic Lymphocytic Leukemia
Authors: Weiguo Han, Aisharya Bhattacharya, Wenzhi Ji, Basel A. Karim, Roman C. Sarott, Meredith Nix, Sai Gourisankar, Andrey Krokhotin, Sutapa Sinha, Zhiquan Wang, Tait D. Shanafelt, Sameer A. Parikh, Nathanael S. Gray, Gerald R. Crabtree, Neil E. Kay
Journal: Blood (2024)
Response Rate, Event-Free Survival (EFS), and Overall Survival in Higher-Risk Myelodysplastic Syndromes (MDS): U.S. Food and Drug Administration (FDA) Trial-Level and Patient-Level Analyses
Authors: Nina Kim, Xin Wang, Ilynn Bulatao, Jonathon Vallejo, Yuan Li Shen, Dianne D. Pulte, Marc R. Theoret, R. Angelo De Claro, Kelly J. Norsworthy
Journal: Blood (2024)
Cytogenetic Abnormalities Following CAR T Cell Therapy for B-Cell Malignancies
Authors: Na Hyun Kim, Fatima Khamissi, Kathleen Bone, Nathan Kopp, Walter Longo, Bryon D. Johnson, Tyce Kearl, Peiman Hematti, Mehdi Hamadani, Timothy S. Fenske, Nirav N. Shah
Journal: Blood (2024)
Association of Body Composition Factors and Toxicity in Patients with Advanced Stage Hodgkin Lymphoma Receiving BV-AVD
Authors: Michele D. Stanchina, Russ Kuker, Sunwoo Han, Fei Yang, Mark K Polar, Jillian Lorayne Lykon, Tracy Crane, Melissa Lopez-Pentecost, Craig H. Moskowitz, Juan Pablo Alderuccio
Journal: Blood (2024)
PRIMAVERA: A Modular Phase I/II Study to Evaluate the Safety, Tolerability, and Efficacy of AZD3470, a Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor, in Participants with Relapsed/Refractory Hematologic Malignancies
Authors: Tae Min Kim, Katharine L. Lewis, Juan Pablo Alderuccio, Hun Ju Lee, Enrico Derenzini, Pier Luigi Zinzani, Marco Ladetto, Elizabeth H. Phillips, Hervé Ghesquieres, François Lemonnier, Franck Morschhauser, Ana Sureda Balari, Antonia Rodriguez Izquierdo, Peter Borchmann, Matthew Weinstock, Jakub Svoboda, Emma Dean, Jelena Urosevic, Stefanie Meyer, Robert Chen, Richard Olsson, Kaitlyn Beyfuss, Graham P. Collins
Journal: Blood (2024)
Establishing a Patient-Derived Immortalized Erythroid Progenitor Cell Model to Investigate Disease Mechanisms and Lentiviral Gene Therapy Vector in Congenital Dyserythropoietic Anemia Type II
Authors: Ravina Taak, Dinesh Babu, Manu Jamwal, Dhavapriya Palani, Prashant Sharma, Prateek Bhatia, Deepak Bansal, Shaji R Velayudhan, Reena Das
Journal: Blood (2024)
Ex Vivo Expansion of Human Hematopoietic Stem Cells By Mimicking Intrinsic and Extrinsic Factors in Adult Bone Marrow
Authors: Xinjian Mao, Ning Zhang, Xi He, Ruochen Dong, Zhe Yang, Michael Epp, Linda Zhang, Allison Scott, Kate Hall, Anoja Perera, Jeff Haug, Hua Li, Cheng Luo, Chuan He, Linheng Li
Journal: Blood (2024)
Elevated Microclots with Low D-Dimer As an Indicator of Impaired Plasmin Generation in Patients with Viral Infections
Authors: Dlovan F. D Mahmood, Ilaria De Simone, Martha M.S. Sim, Hammodah R. Alfar, Ziyu Zhang, Wen Dai, Gabriel D. Schmuck, Bas De Laat, Dana Huskens, Ze Zheng, Jeremy P. Wood
Journal: Blood (2024)
Two-Year Follow-up after Ibrutinib and Venetoclax in Symptomatic, Treatment-Naive Patients with Waldenström Macroglobulinemia
Authors: Jorge J. Castillo, Shayna R Sarosiek, Andrew R. Branagan, Gottfried von Keudell, Catherine A. Flynn, Andres Ramirez-Gamero, Nina S Budano, Alexandra N. Eurell, Kirsten Meid, Maria Luisa Guerrera, Amanda Kofides, Shirong Liu, Xia Liu, Kris Richardson, Nickolas Tsakmaklis, Christopher J Patterson, Zachary R Hunter, Steven P. Treon
Journal: Blood (2024)
Central Nervous System Disorders (CNSD) Following Hematopoietic Stem Cell Transplantation (HSCT): A Prospective Study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP), European Society of Blood and Marrow Transplantation (EBMT)
Authors: Martin Schmidt-Hieber, Per T. Ljungman, Patrick Gilbert, Nina Knelange, Joanna Drozd-Sokolowska, Grzegorz Basak, Hermann Einsele, Gloria Tridello, Nour Ben Abdeljelil, Alexander Kulagin, Aitana Balaguer Rosello, Elisabetta Metafuni, Maura Faraci, Jolanta Gozdzik, Rodrigo Martino, Anna Maria Raiola, Regis Peffault De Latour, Baris Kuskonmaz, Alessandra Biffi, Krzysztof Czyzewski, Melissa Ann Gabriel, Joaquín Martínez-Lopez, Malgorzata Mikulska, Zinaida Peric, Dina Averbuch, Jan Styczynski, Rafael De La Camara
Journal: Blood (2024)
A Prospective Analysis of Outcomes Following Successive Lines of Treatment in Mantle Cell Lymphoma in an Unselected Previously Untreated Population: The UK MCL Biobank
Authors: Sarah Mant, Georgina Naylor, Nicola Crosbie, Sree Aroori, Mark J Bishton, Kristian Bowles, Safia Dawi, Toby A. Eyre, Wendy Ingram, Abigail Martin, Christopher McNamara, Melanie Oates, Andrew Pettitt, Claire Scully, Brian Wainman, Mark Warner, Simon Rule, David John Lewis
Journal: Blood (2024)
Preliminary Efficacy and Safety of the Bruton Tyrosine Kinase Degrader BGB-16673 in Patients with Relapsed or Refractory (R/R) Indolent NHL: Results from the Phase 1 CaDAnCe-101 Study
Authors: Constantine S. Tam, Anna Maria Frustaci, Fontanet Bijou, Pier Luigi Zinzani, John F. Seymour, Masa Lasica, Herbert A. Eradat, Victor T.G. Lin, Maan Alwan, Irina Mocanu, Xiangmei Chen, Kunthel By, Shannon Fabre, Daniel O. Persky, Amit Agarwal, Chan Y. Cheah
Journal: Blood (2024)
Retreatment with R-CHOP-like Therapy Is Active with Durable Responses in Patients with Late Relapse of Diffuse Large B-Cell Lymphoma
Authors: Eduardo Edelman Saul, Bryan Valcarcel, Amy A. Ayers, Mansoor Noorani, Dai Chihara, Fateeha Furqan, Sairah Ahmed, Swaminathan P Iyer, Sattva S. Neelapu, Luis E. Fayad, F. B. Hagemeister, Chijioke Nze, Preetesh Jain, Michael Wang, Paolo Strati, Ayushi Chauhan, Francisco Vega, Christopher R. Flowers, Jason R. Westin
Journal: Blood (2024)
1‰ Regular Dose of Metabolically Armored CD19 CAR-T Cells Induces Robust <i>in vivo</i> Expansion and Complete Remission in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients
Authors: Yongxian Hu, Mingming Zhang, Shan Fu, Ruimin Hong, Jiazhen Cui, Simao Huang, Min Gao, Daojun Bai, Jingjing Ren, Xingbing Wang, Yugang Guo, Li Tang, He Huang
Journal: Blood (2024)